Upload
sandeep-kumar
View
212
Download
0
Embed Size (px)
Citation preview
www.elsevier.com/locate/pharmthera
Pharmacology & Therapeutics 101 (2004) 211–226
Associate editor: D.R. Sibley
Ethanol regulation of g-aminobutyric acidA receptors: genomic and
nongenomic mechanisms
Sandeep Kumar, Rebekah L. Fleming, A. Leslie Morrow*
Departments of Psychiatry and Pharmacology, Center For Alcohol Studies, University of Chapel Hill at North Carolina, CB#7178,
Chapel Hill, NC 27599, USA
Abstract
g-Aminobutyric acidA (GABAA) receptors are ligand-gated ion channels that, predominately, mediate inhibitory synaptic transmission in
the CNS. These receptors are pentameric complexes that are comprised of subunits from several classes (a, h, g, y, q), with each class
consisting of several isoforms. Chronic ethanol consumption alters GABAA receptor function producing cellular tolerance to GABA and
ethanol, cross-tolerance to benzodiazepines and barbiturates, and sensitization to inverse agonists. Recent studies have clearly demonstrated
that GABAA receptors play an important role in ethanol dependence and functional properties of GABAA receptor are altered following
chronic ethanol administration. However, the exact mechanisms that account for alterations in GABAA receptor function following chronic
ethanol administration have not been resolved. The mechanisms responsible for adaptation of GABAA receptors to chronic ethanol exposure
may involve ethanol-induced changes in cell surface expression, subcellular localization, synaptic localization, receptor phosphorylation,
neurosteroids, and/or changes in GABAA receptor subunit composition. In this review, we provide an overview of recent data pertaining to
mechanisms that could be responsible for altered properties and expression of GABAA receptors following chronic ethanol administration.
D 2004 Elsevier Inc. All rights reserved.
Keywords: GABAA receptor expression; Subcellular localization; Synaptic localization; Receptor phosphorylation; Neurosteroids; Protein kinase C
Abbreviations: AKAP, A kinase anchoring proteins; AP2, adaptor complex-2; BDNF, brain-derived neurotrophic factor; CaMK, Ca2+/calmodulin-dependent
protein kinase; CCV, clathrin-coated vesicles; CIE, chronic intermittent ethanol exposure; DARP-32, dopamine and cyclic AMP-regulated phosphoproteins;
GABAA, g-aminobutyric acidA; 5-HT, serotonin; GST, glutathione-S transferase; mACh, muscarinic acetylcholine; mIPSC, miniature inhibitory postsynaptic
current; NMDA, N-methyl-D-aspartate; PKA, protein kinase A; PKC, protein kinase C; QT-6, quail fibroblast cells; RACK, receptor for activated kinase C;
THDOC, tetrahydroxydeoxycorticosterone or 3a,21-dihydroxy-5a-pregnan-20-one; 3a,5a-THP, 3a-hydroxy-5a-pregnan-20-one.
Contents
1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 212
2. Effects of ethanol on g-aminobutyric acidA receptors. . . . . . . . . . . . . . . . . . . . . . . 212
3. Effects of prolonged ethanol exposure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 213
4. Mechanisms of g-aminobutyric acidA receptor adaptations following ethanol exposure . . . . . 214
4.1. Alterations of g-aminobutyric acidA receptor gene expression . . . . . . . . . . . . . . 214
4.2. Post-translational modification . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 215
4.3. Subcellular localization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 217
4.4. Synaptic localization of receptors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 218
4.5. Regulation of g-aminobutyric acidA receptors by other receptors via intracellular
signaling systems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 219
4.6. Role of neurosteroids in ethanol tolerance and dependence . . . . . . . . . . . . . . . . 220
5. Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 221
Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 222
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 222
0163-7258/$ – see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.pharmthera.2003.12.001
* Corresponding author. Tel.: 919-966-7682; fax: 919-966-9099.
E-mail address: [email protected] (A.L. Morrow).
S. Kumar et al. / Pharmacology & Therapeutics 101 (2004) 211–226212
1. Introduction
g-Aminobutyric acidA (GABAA) receptors are a family
of chloride ion channels that mediate inhibitory neurotrans-
mission throughout the CNS. These receptors are hetero-
meric protein complexes consisting of several homologous
membrane-spanning glycoprotein subunits. Molecular clon-
ing has revealed multiple GABAA receptor subunits that
can be divided by homology into subunit classes with
several members: a1–6, h1–4, g1–3, y, q, and k (Sieghart
& Sperk, 2002). The majority of GABAA receptors are
composed of 2 a-, 2 h-, and 1 g-subunits, where the g-
subunit is located between a- and h-subunits (Tretter et al.,1997; Sieghart et al., 1999) and expressed on cell mem-
branes to inhibit neuronal signaling (Sieghart, 2000). The
large number of GABAA receptor subunits generates the
potential for various subunit compositions that may ac-
count for variable sensitivity to modulatory drugs, such as
benzodiazepines, barbiturates, neurosteroids, and possibly
alcohol and general anesthetics. GABAA receptors have
been divided into multiple subtypes based on different
receptor distributions in brain and the pharmacological
profiles of several compounds (Seeburg et al., 1990).
Recombinant expression studies have demonstrated that
subunit composition determines the functional properties
of receptor subtypes. Type I benzodiazepine receptor char-
acteristics are observed with receptors consisting of
a1hxg2-subunits. By contrast, the expression of a2hxg2,
a3hxg2, or a5hxg2-subunits results in type II benzodiaze-
pine site pharmacology (Sieghart, 1989). Other GABAA
receptors are insensitive to benzodiazepines, including a4yand a6y receptors (Sieghart & Sperk, 2002). For example,
substitution of a4 for a1-subunits in recombinant receptors
produces particularly remarkable effects on GABA and
benzodiazepine sensitivity (Wafford et al., 1996; Whitte-
more et al., 1996). Notably, these changes in receptor
Table 1
Proteins associated with GABAA receptors
Proteins Method Brain area/cell type
PKCg co-immunoprecipitation cerebral cortex
PKCq confocal microscopy brain
PKCh11 co-immunoprecipitation cortical neurons
RACKI co-immunoprecipitation HEK 293 cells/brain
cortical neurons
Serine kinase
(GTAP 34)
co-immunoprecipitation brain (calf)
Gephyrin confocal microscopy brain
Adaptin-a/clathrin co-immunoprecipitation/
confocal microscopy
cerebral cortex/
hippocampus
AKAP 150/PKA co-immunoprecipitation/
confocal microscopy
adult brain/cultured
hippocampal cells
GABARAP GST pull-down assay/
co-immunoprecipitation/
confocal microscopy
yeast cells/brain/QT-
quail fibroblast
pharmacology are mimicked in vivo following drug-in-
duced adaptations in receptor subunit gene expression
(Grobin et al., 1998). The GABAA receptor a1-subunit is
the most abundant a-subunit in adult brain, highly
expressed throughout most brain regions and is a compo-
nent of f 50% of all GABAA receptors (Kralic et al.,
2002a). The analysis of subunit composition by co-immu-
noprecipitation studies have demonstrated that 98% of a1-
subunit-containing receptors are assembled with a g- or y-subunit (Sieghart & Sperk, 2002). In contrast, a significant
fraction of a4-subunit-containing receptors are comprised
of a4- and h-subunits only (Bencsits et al., 1999). GABAA
receptors also associate with various other proteins (see
Table 1) that anchor the receptor, mediate trafficking and
post-translational modifications, and modulate receptor
function under various conditions. These protein interac-
tions are not yet well understood, but clearly influence
GABAA receptor assembly, expression on the membrane
surface, endocytosis, and channel function that ultimately
controls the inhibitory tone of the CNS.
2. Effects of ethanol on ;-aminobutyric acidA receptors
Ethanol has many sites of action in the brain, but few
have been linked as closely to its behavioral actions as
GABAA receptors. At low doses, ethanol is anxiolytic,
sedative-hypnotic, anticonvulsant, motor-incoordinating,
and impairs cognitive function (Majchrowicz, 1975; Frye
et al., 1981; Matthews et al., 1995; Givens & McMahon,
1997). These behavioral effects of acute ethanol adminis-
tration are remarkably similar to those of known GABAA
receptor modulators, including benzodiazepines, barbitu-
rates, and 3a,5a-reduced neuroactive steroids.
Many laboratories have attempted to demonstrate that
physiological concentrations of ethanol alter GABAA re-
Receptor type/subunit Reference
a1/a4-subunit-
containing receptors
Kumar et al., 2002
a1-, h2/3-, or g2-subunit Olive & Hodge, 2000
h1/h3-subunit Brandon et al., 1999
/ h1/h3 Brandon et al., 1999
h3-subunit Kannenberg et al., 1999
a1-, a2-, a3-, or g2-
subunit-containing
receptors
Sassoe-Pognetto et al., 2000
a1-subunit-containing
receptors/h- and g-subunits
Kittler et al., 2000;
Kumar et al., 2003b
h1/h3 Brandon et al., 2003
6 g (g2) Chen et al., 2000; Wang
& Olsen, 2000; Nymann-
Andersen et al., 2002
Table 2
Effects of chronic ethanol administration on GABAA receptor function in
the cerebral cortex, hippocampus, and cerebellum
Receptor property Alteration Source
GABA-mediated Cl �
channel function1,2decreased Martz et al., 1983;
Morrow et al., 1988;
Gonzalez & Czachura,
1989; Criswell et al.,
1993; Kang et al., 1998;
Cagetti et al., 2003
GABA-mediated Cl �
channel function3no change Allan & Harris, 1987;
Buck & Harris, 1990;
Frye et al., 1993
Pentobarbital-mediated
Cl� flux1decreased Morrow et al., 1988
Ethanol-enhanced
Cl� flux3abolished Allan & Harris, 1987;
Morrow et al., 1988
Benzodiazepine-
enhanced Cl � flux2,3decreased Buck & Harris, 1990;
Cagetti et al., 2003
Inverse agonist
modulation2,3increased Mehta & Ticku, 1989;
Buck & Harris, 1990;
Cagetti et al., 2003
Neuroactive steroid
modulation1,2increased Devaud et al., 1996;
Cagetti et al., 2003
1 Cerebral cortex.2 Hippocampus.3 Cerebral cortex and cerebellum.
S. Kumar et al. / Pharmacology & Therapeutics 101 (2004) 211–226 213
ceptor function; however, whether ethanol directly affects
GABAA receptors remains controversial. In vivo studies
examining ethanol interactions with GABAA receptors give
mixed results, suggesting that complex mechanisms are
involved in the actions of ethanol. Acute ethanol adminis-
tration potentiates GABA-mediated inhibition in vivo, but
only in specific brain regions or cell types (Celentano et al.,
1988; Givens & Breese, 1990; Proctor et al., 1992; Rey-
nolds et al., 1992; Aguayo et al., 1994; Frye et al., 1994;
Soldo et al., 1994; Sapp & Yeh, 1998). Ethanol has been
shown to alter GABAergic synaptic transmission in both the
hippocampus (Weiner et al., 1994) and the amygdala (Rob-
erto et al., 2003). Ethanol increased mean open time,
frequency of opening, and burst duration, while decreasing
mean closed time of GABAA receptors in dorsal root
ganglion cells (Takebayashi et al., 1998). Other studies
indicate that direct interaction of ethanol with neuronal
GABAA receptors using patch clamp recording techniques
is absent or minimal at pharmacologically relevant ethanol
concentrations (Frye et al., 1994; Crews et al., 1996;
Marszalec et al., 1998).
Ethanol potentiation of GABA responses at remarkably
low concentrations (1–5 mM) has recently been demon-
strated in recombinant GABAA receptors containing a4y-and a4h3y-subunits in oocytes (Sundstrom-Poromaa et al.,
2002; Wallner et al., 2003). Furthermore, this high ethanol
sensitivity is recapitulated in vivo in progesterone-with-
drawn animals that exhibit an increase in the expression
of this receptor subtype in the hippocampus (Sundstrom-
Poromaa et al., 2002). Notably, many other recombinant
GABAA receptors are insensitive to low ethanol concen-
trations ( < 50 mM) in any expression system (Harris et al.,
1998), including chimeric GABA/glycine receptors that
respond to alcohols at high mM concentrations (Mihic et
al., 1997).
Multiple mechanisms may influence the sensitivity of
GABAA receptors to ethanol. In some studies, certain exper-
imental conditions have been manipulated to uncover an
effect of ethanol (Weiner et al., 1994, 1997a; Wan et al.,
1996). h-Adrenergic receptor stimulation and subsequent
elevation of cAMP and protein kinase A (PKA) activity are
required to detect ethanol potentiation of GABA in cerebellar
Purkinje cells (Freund & Palmer, 1997; Wang et al., 1999).
Furthermore, elevation of protein kinase C (PKC) in hippo-
campal slices increased the sensitivity of CA1 neurons to
ethanol (Weiner et al., 1997b). Endogenous neurosteroids
may also play an important role in the complex interactions
between ethanol and GABAA receptors. Systemic ethanol
administration dramatically elevates both plasma and cere-
bral cortical 3a-hydroxy-5a-pregnan-20-one (3a,5a-THP)
and 3a,21-dihydroxy-5a-pregnan-20-one (THDOC) to phar-
macologically active levels (Morrow et al., 1998; Barbaccia
et al., 1999). A growing body of evidence suggests that brain
concentrations of endogenous neurosteroids could modulate
the behavioral and/or electrophysiological effects of ethanol
discussed above (see Morrow et al., 2003, for a review).
3. Effects of prolonged ethanol exposure
Prolonged ethanol consumption results in the develop-
ment of tolerance to many of the GABAergic effects of
ethanol including the anxiolytic, sedative, motor-in-coordi-
nating, and positive reinforcing effects of ethanol. With-
drawal from ethanol and, particularly, repeated withdrawals
from ethanol produce marked increases in CNS excitability
that form a criterion for ethanol dependence. Substantial
evidence suggests that these behavioral and neural adapta-
tions involve marked adaptations in the pharmacological
properties of GABAA receptors. The molecular determi-
nants of these alterations in GABAA receptor function are
complex, probably due to the heterogeneity of GABAA
receptor subtypes and the diversity of biochemical mecha-
nisms that regulate the function of these receptors.
The development of ethanol tolerance and dependence is
associated with alterations in many of the functional prop-
erties of GABAA receptors throughout brain (Table 2). In
the cerebral cortex, muscimol- and pentobarbital-stimulated
Cl � uptake is decreased following chronic ethanol expo-
sure. The ability of ethanol to potentiate GABA- or musci-
mol-stimulated Cl� uptake is lost following chronic ethanol
administration in both cortex and cerebellum. Benzodiaze-
pine enhancement of muscimol-stimulated chloride flux is
reduced in the cerebral cortex of mouse microsacs, while the
functional efficacy of inverse agonists is enhanced. Poten-
tiation of Cl � uptake by the neuroactive steroids, 3a,5a-
THP and THDOC, is enhanced in ethanol-dependent rats
(Devaud et al., 1996). Furthermore, chronic intermittent
ethanol exposure (CIE) produces many changes in hippo-
S. Kumar et al. / Pharmacology & Therapeutics 101 (2004) 211–226214
campal GABAA receptor function and pharmacology.
GABA-activated Cl � flux in hippocampal slices is reduced
following CIE (Kang et al., 1998). Hippocampal cells
become insensitive to alphaxalone and diazepam but re-
spond to bretazenil as an agonist and Ro15-4513 binding is
increased (Cagetti et al., 2003). Therefore, it is clear that
chronic ethanol exposure leads to altered properties of
GABAA receptors.
4. Mechanisms of ;-aminobutyric acidAreceptor adaptations following ethanol exposure
The precise mechanisms that account for alterations in
GABAA receptor function and increased CNS excitability
following chronic ethanol administration are becoming clear.
Several mechanisms for GABAA receptor adaptation follow-
ing chronic ethanol exposure have been proposed, which
include alterations in gene expression, post-translational
modification, subcellular localization, synaptic localization,
regulation by other receptor interactions, intracellular sig-
naling, and neurosteroid responses to ethanol (Fig. 1). These
mechanisms include both genomic and nongenomic alter-
ations that are likely to interact to explain the complex
adaptations of GABAA receptors to ethanol throughout
brain. The purpose of this review is to discuss evidence that
these adaptations underlie ethanol regulation of GABAA
Fig. 1. Potential mechanisms of GABAA receptor regulation following chronic et
receptor assembly: Chronic ethanol administration results in altered mRNA and pe
regulation of subunit expression varies across brain regions. Altered subunit expr
composition and function of cell surface GABAA receptors. Internalization: Chron
receptors internalized in CCV (see Section 4.3). Internalized receptor can be degrad
processes. Internalized receptor subunits could also provide signals that contribute
(see Section 4.2): Chronic ethanol exposure alters receptor function without altering
is exogenously controlled. Chronic ethanol exposure reduces the level of phosphor
translational modification of receptor subunits could alter receptor function by a
translational modification of receptor subunits and/or associated proteins could als
of GABAA receptors and regulate their expression in vivo (see Section 4.6). NM
modulated by ethanol and can indirectly modulate GABAA receptor function v
proteins involved in these actions include PKC, PKA, CaMK, Ca2+, and DARP-
receptor function and highlight recently discovered mecha-
nisms that may play an important role in pharmacological
adaptations to ethanol.
4.1. Alterations of c-aminobutyric acidA receptor gene
expression
Recombinant expression and homologous gene deletion
studies have shown that functional properties of receptors
are regulated by the subunit composition of receptors. For
example, recombinant GABAA receptors with a4h2g2-sub-
units respond to GABA and benzodiazepine agonists with
lower efficacy than a1h2g2 receptors (Whittemore et al.,
1996). Moreover, homologous genetic deletion of a1-sub-
units dramatically alters the pharmacological properties of
GABAA receptors, reducing the potency and efficacy of
GABA and the benzodiazepine, diazepam. Furthermore,
these mice exhibit increased seizure susceptibility and a
reduction in the anticonvulsant actions of benzodiazepines
(Kralic et al., 2002a, 2002b).
Chronic ethanol administration differentially alters the
expression of distinct GABAA receptor subunit mRNA and
peptides in various brain regions. The level of GABAA
receptor a1-, a2-, and a3-subunit mRNA and peptides are
reduced in the cerebral cortex (Mhatre & Ticku, 1992;
Devaud et al., 1997), while a4-, h1-, h2-, h3-, g2-, and g2-
subunit peptide or mRNA levels are increased in the
hanol administration. From right to left: Altered mRNA, peptide levels and
ptide levels of various GABAA receptor subunits (see Section 4.1). Ethanol
ession could modify receptor assembly resulting in a change in the subunit
ic ethanol administration causes an increase in GABAA receptor a1-subunit
ed or recycled back to the cell surface and PKC has been implicated in both
to the regulation of receptor gene expression. Post-translational modification
receptor subunit expression in recombinant systems where gene expression
ylated a1-subunit containing GABAA receptors or associated proteins. Post-
ltering receptor conformation and/or channel conductance. However, post-
o alter receptor trafficking. Neurosteroids: Neurosteroids alter the sensitivity
DA, mACh, 5-HT, h-adrenergic receptor cross-talk: These receptors are
ia various intracellular signaling proteins (see Section 4.5). The signaling
32.
Table 3
Consensus sites for phosphorylation in GABAA receptor subunits
h1 – 4 PKC, PKA, CaMKII Wisden et al., 1991;
g2 S/L PKC, CaMKII Moss et al., 1992a;
a4 PKC, PKA Macdonald, 1995;
a6 PKC, PKA Mohler et al., 1996
S. Kumar et al. / Pharmacology & Therapeutics 101 (2004) 211–226 215
cerebral cortex following chronic ethanol exposure (Devaud
et al., 1997; Mahmoudi et al., 1997; Matthews et al., 1998a).
Since a1-subunits are the most abundant subunit in the
cerebral cortex, the reduction in the expression of this
subunit is likely to have significant functional consequen-
ces. GABAA receptor a4-subunit expression measured by
immunohistochemical labeling in brain sections is sparse
across most brain regions except the thalamus (Bencsits et
al., 1999; Pirker et al., 2000; Peng et al., 2002). However,
selective modulation of a4-subunit expression in the hippo-
campus using antisense oligonucleotides has been shown to
significantly alter the functional properties of GABAA
receptors and modulate steroid withdrawal excitability
(Moran et al., 1998). Therefore, despite the relatively low
expression of a4-subunit peptide, modulation of a4-subunit
expression clearly influences GABAA receptor function and
GABA-mediated behaviors in vivo. Hence, alterations in
GABAA receptor subunit expression appear critically im-
portant in regulation of GABAA receptor function following
chronic ethanol administration.
The regulation of various GABAA receptor subunits by
ethanol differs across brain regions (Grobin et al., 2000).
For example, chronic ethanol consumption for 14 days
increases GABAA receptor a4-subunit expression in the
cerebral cortex and hypothalamus (Devaud et al., 1997),
decreases a4-subunit levels in that amygdala and nucleus
accumbens (Papadeas et al., 2001), and does not alter a4-
subunit levels in the hippocampus or ventral tegmental
area (Matthews et al., 1998a; Papadeas et al., 2001).
However, repeated ethanol withdrawals or longer ethanol
exposure increases a4-subunit expression in the hippo-
campus (Matthews et al., 1998a; Cagetti et al., 2003), and
these effects are associated with alterations in the phar-
macological responses of GABAA receptors to benzodi-
azepine agonists and inverse agonists (Cagetti et al.,
2003). Furthermore, in the cerebellum, a6-subunit mRNA
and peptide levels are increased while a1-subunit peptide
and mRNA are decreased following chronic ethanol
administration (Morrow et al., 1992; Mhatre & Ticku,
1993). Therefore, it is clear that adaptation in GABAA
receptor subunit expression caused by chronic ethanol
administration is not universal across brain regions. The
mechanisms that underlie regional differences in the
regulation of GABAA receptors by ethanol are unclear
but may involve mechanisms to be described in the
following sections.
4.2. Post-translational modification
Protein phosphorylation is a common regulatory mech-
anism for maintaining receptor structure and function and
has been implicated in modulation of GABAA receptor
function under numerous physiologic conditions (Kellen-
berger et al., 1992; Leidenheimer et al., 1992; Krishek et
al., 1994; Poisbeau et al., 1999; Brandon et al., 2000).
GABAA receptor phosphorylation can cause diverse func-
tional effects, ranging from enhancement to inhibition
depending upon the sites phosphorylated (Lin et al.,
1996; McDonald et al., 1998). Several protein kinases
including PKC, PKA, and Ca2 + /calmodulin-dependent
protein kinase-II (CaMKII) have consensus sites on
GABAA receptor subunits and can phosphorylate these
subunits (McDonald & Moss, 1997; Brandon et al., 2000)
(see Table 3). Enzyme substrate co-localization is important
for substrate activation and provides substrate specificity
for kinases. Targeting of protein kinases to GABAA recep-
tors can be a critical factor in controlling the functional
modulation of receptors by phosphorylation and several
intermediary proteins can regulate this process. Intermedi-
ary proteins that are important for transportation and
anchoring of PKC and PKA are receptor for activated
kinase C (RACK) and A kinase anchoring proteins
(AKAP), respectively. Recent studies have shown that
GABAA receptors are closely associated with several sig-
naling proteins (see Table 1), including PKC and PKA, that
can alter receptor function.
PKC phosphorylation of GABAA receptor subunits reg-
ulates GABAA receptor function (Poisbeau et al., 1999;
Brandon et al., 2000), expression (Chapell et al., 1998;
Connolly et al., 1999), and adaptation following ethanol
exposure (Kumar et al., 2002). There are 3 major classes of
PKC: cPKC (Ca2 + -dependent PKCa, h, and g), nPKC
(Ca2 + -independent y and q), and aPKC (atypical or Ca2 + -
and phorbol ester-independent ~). Despite the existence of
several isoforms of PKC, previous studies have demonstrat-
ed that only h, g, and q isoforms interact with GABAA
receptors and modulate receptor function (Connolly et al.,
1999; Hodge et al., 1999; Brandon et al., 2000; Olive &
Hodge, 2000; Kumar et al., 2002). PKCg co-immunopreci-
pitates with GABAA receptors isolated with both a1- and
a4-subunit antibodies in the cerebral cortex (Kumar et al.,
2002) and PKCq co-localizes with various GABAA receptor
subunits across brain (Olive & Hodge, 2000). Genetic
deletion of PKCg and q has clearly demonstrated that these
isoforms of PKC modulate the effects of ethanol on GABAA
receptors both in vitro and in vivo (Proctor et al., 2003). For
example, PKCg null mice show reduced sensitivity to the
anxiolytic effects of both intoxicating and sedative doses of
ethanol when compared with wild-type mice (Bowers et al.,
2001), while PKCq null mice show increased ethanol
sensitivity (Hodge et al., 1999). Furthermore, mice lacking
the gene for PKCg show a significant reduction in ethanol
potentiation of muscimol-stimulated Cl � influx compared
with responses in wild-type mice (Harris et al., 1995). In
S. Kumar et al. / Pharmacology & Therapeutics 101 (2004) 211–226216
contrast, ethanol and flunitrazepam potentiation of musci-
mol-stimulated Cl � uptake is greater in microsacs from
PKCq null mutant mice compared with wild-type controls
(Hodge et al., 1999). Therefore, it appears that q and g
isoforms of PKC have opposing effects on GABAA receptor
function. Furthermore, there are quantitative and qualitative
differences in expression of PKC isoforms in brain and
nonneuronal cells. For example, PKCg is only present in the
CNS, and its expression varies across brain regions (Kik-
kawa et al., 1989; Wetsel et al., 1992). In the cerebellum,
PKCg is highly expressed in Purkinje cells but not in other
neurons (Yoshida et al., 1988; Kikkawa et al., 1989;
Barmack et al., 2000). Taken together, it is likely that both
PKCg and q mediate phosphorylation of GABAA receptors
and/or associated proteins and regulate GABAA receptor
function in a cell-specific manner.
Studies have suggested that altered phosphorylation of
GABAA receptor subunits mediates changes in receptor
function following ethanol exposure, since ethanol can alter
GABAA receptor function under conditions where subunit
expression is fixed (Klein et al., 1995). Direct phosphory-
lation of receptor subunits can alter function by altering the
conformational state of the receptor that could either alter
the binding of GABA or alter channel conductance inde-
pendently (Churn & DeLorenzo, 1998; Oh et al., 1999;
Churn et al., 2002). Studies using recombinant GABAA
receptor subunits have shown that PKC phosphorylation of
a1-, h2-, and g2-subunits produces inhibition of GABAA
receptor-stimulated current (Kellenberger et al., 1992;
Krishek et al., 1994). However, the evidence for a role of
phoshorylation of native GABAA receptors is controversial
(Heuschneider & Schwartz, 1989; Leidenheimer et al.,
1990, 1992; Ticku & Mehta, 1990; Ghansah & Weiss,
2001). We have recently found preliminary evidence that
adenosine triphosphate and the phorbol ester phorbol 12,13-
dibutyrate enhance the phosphorylation of type 1 GABAA
receptors and reduce muscimol-stimulated Cl � uptake in
rat cerebral cortical synaptoneurosomes when synaptoneur-
osomes are prepared in the presence of co-factor and/or
activator (Kumar et al., 2003a). Similarly, PKCq-mediated
phosphorylation inhibits ethanol and benzodiazepine
responses, since PKCq inhibition or deletion enhances
benzodiazepine and ethanol potentiation of GABA
responses in synaptoneurosomes (Hodge et al., 1999). In
contrast, PKC activation enables the allosteric enhancement
of synaptic GABA currents by neurosteroids (Leidenheimer
& Chapell, 1997; Fancsik et al., 2000).
Chronic ethanol exposure diminishes GABA and benzo-
diazepine responses, yet it enhances neurosteroid potentia-
tion of GABAA receptors in cortical synaptoneurosomes
(Devaud et al., 1996). Similar responses are observed in
hippocampal neurons following chronic ethanol administra-
tion (Cagetti et al., 2003). Therefore, it might be predicted
that chronic ethanol administration would increase PKC
phosphorylation of GABAA receptors. However, the lack
of phospho-specific antibodies against GABAA receptor
subunits has precluded study of phosphorylation state of
receptor subunits in vivo. To address this question, we
investigated the effect of chronic ethanol administration on
the association of PKCg with a1-subunit-containing
GABAA receptors in cerebral cortical membranes. Chronic
ethanol exposure reduced co-immunoprecipitation of PKCg
with these receptors (Kumar et al., 2002). To measure the
level of phosphorylated a1-subunit-containing GABAA
receptors in the synaptic membrane fraction, phosphopro-
teins were immunoprecipitated and GABAA a1-subunits
were identified in the denatured phospho-immunoprecipi-
tate. Preliminary data suggest that chronic ethanol exposure
reduces the levels of phosphorylated a1-subunit-containing
GABAA receptors and/or associated proteins in the mem-
brane fraction of cerebral cortex (Fig. 2). Studies on the
phosphorylation state of a4-subunit-containing receptors are
underway. These studies will address the possibility that
altered phosphorylation of receptors may contribute to
altered function of GABAA receptors either via direct effects
on receptor function or effects on receptor trafficking (see
Section 4.3).
Other protein kinases can also modulate GABAA recep-
tor function by phosphorylation of GABAA receptor sub-
units. The activation of PKA can increase or decrease in
GABA-activated currents depending upon the cell type. For
example, PKA activation causes a decrease in GABA-
activated currents in cultured cerebellar granule cells,
hippocampal pyramidal cells, and spinal cord neurons
(Porter et al., 1990; Moss et al., 1992b; Robello et al.,
1993; Poisbeau et al., 1999). In contrast, PKA activation
increases GABAA receptor response in hippocampal den-
tate granule neurons and cerebellar Purkinje neurons (Kano
& Konnerth, 1992; Kano et al., 1992; Nusser et al., 1999).
These contradictory responses following PKA activation
could be due to the presence of different GABAA receptor
subtypes in various cells. In addition, there are cell-specific
differences in the expression of PKA isozymes and AKAP
(Ulfig & Setzer, 1999; Sik et al., 2000). PKA modulation
of GABAA receptors may be relevant to ethanol-induced
receptor adaptations. PKA-mutant mice consume more
ethanol and show low sensitivity to ethanol-induced seda-
tion compared with wild-type mice (Thiele et al., 2000).
Furthermore, chronic ethanol administration alters translo-
cation of PKA (Dohrman et al., 2002). Hence, PKA can
modulate GABAA receptor function and may contribute to
development of ethanol dependence following chronic
ethanol administration.
The phosphorylation state of a given protein is governed
by the balance between protein kinases that transfer phos-
phate from adenosine triphosphate to the protein (phos-
phorylation) and protein phosphatases that catalyze the
reverse reaction (dephosphorylation). It is now widely
acknowledged that the regulation of protein phosphoryla-
tion requires coordinated control of both kinases and
phosphatases. Chronic ethanol exposure alters PKC levels
in PC-12 cells (Messing et al., 1991) and membrane
Fig. 2. Chronic ethanol administration decreases phosphorylated a1-subunit-containing GABAA receptors. Ethanol was administered to male Sprague-Dawley
rats for 2 weeks using a pair-fed design as previously described (Devaud et al., 1997). On day 15, animals were sacrificed and cerebral cortex was dissected and
stored at � 80 jC. The synaptic fraction of cortex was solubilized and immunoprecipitated using a Phosphoprotein Purification Kit (Qiagen, Valencia, CA) that
immunoprecipitates any proteins phosphorylated at serine, threonine, and/or tyrosine residues. The phosphoprotein immunoprecipitate was then denatured and
a1-subunit protein was detected by western blot analysis. (A) Chronic ethanol administration decreased the level a1-subunit peptide in the phosphoprotein
immunoprecipitate by 50.98 F 15.38 % ( P = 0.0106, n = 5). (B) To confirm the specificity of the phosphoprotein purification, we dephosphorylated proteins
in the synaptic fraction by incubating synaptic fraction with protein phosphatase enzyme (k-PPase, 40,000 units, Biolabs, New England) in a water bath at 30
jC for 90 min and purified the phosphorylated proteins. No a1-subunit peptide was detected in the phosphoprotein immunoprecipitate of dephosphorylated
proteins following western blot analysis. Therefore, the immunoprecipitation of phosphorylated a1-subunit-containing GABAA receptors was specific and
nonspecific binding of a1-subunits to the phosphoprotein column was undetectable.
S. Kumar et al. / Pharmacology & Therapeutics 101 (2004) 211–226 217
fractions of the frontal and limbic cortices in mice (Narita
et al., 2001), but not in P2 fraction of rat cerebral cortex
(Kumar et al., 2002). The effect of chronic ethanol expo-
sure on protein phosphatase expression and activity is still
not known. However, phosphatase inhibitors alter the
function of GABAA receptors (Huang & Dillon, 1998).
In addition, we recently found that blockade of phosphatase
activity throughout the preparation of cerebral cortical
synaptoneurosomes decreases muscimol-induced chloride
uptake (Kumar et al., 2003a). Hence, the balance between
phosphatase and kinase activity is important for GABAA
receptor function. Chronic ethanol administration could
alter this balance to regulate receptor function and or
trafficking. Further studies on the effects of ethanol on
protein phosphatase activity are warranted.
Alterations in the phosphorylation state of GABAA
receptors could alter receptor function directly or indirectly.
Phosphorylation may directly alter receptor conformation
and channel conductance while indirect actions may pro-
duce alterations in receptor subunit composition at the
membrane surface by altering the normal trafficking of
receptors. This possibility is discussed in Section 4.3.
4.3. Subcellular localization
One mechanism that regulates the strength of synaptic
inhibition involves the density and/or composition of
GABAA receptors on the cell surface. Functional receptors
are expressed on cell membranes, and therefore, cell surface
expression of receptor peptides represents a useful tool for
identification of receptors that are likely functional. The
expression of GABAA receptors involves a highly regulated
process of synthesis, assembly, endocytosis, and recycling
to the membrane or degradation (see Fig. 3). Golgi-derived
vesicles provide newly synthesized receptors to the cell
surface, whereas clathrin-coated vesicles (CCV) mediate
endocytosis of surface receptors that are ultimately degraded
or recycled back to the cell surface (Lodish et al., 1996).
Alterations in the expression and composition of various
GABAA receptors could result from selective endocytosis
and/or recycling to the cell surface.
Chronic ethanol exposure selectively increases the inter-
nalization of a1-subunit-containing GABAA receptors into
CCVof the cerebral cortex with a corresponding decrease in
these receptors in the synaptic fraction (Kumar et al.,
2003b). In contrast, there is no change in the internalization
of a4-subunit-containing receptors into CCV, although there
is a significant increase in a4-subunit peptide in the synaptic
fraction following chronic ethanol exposure. Furthermore,
acute ethanol administration has no effect on the subcellular
localization of either receptor subtype. Hence, the regulation
of intracellular trafficking following chronic ethanol expo-
sure appears to alter the subtypes of GABAA receptors on
the cell surface and this may account for alterations in the
pharmacological properties of GABAA receptors that have
been observed.
Fig. 3. Mechanisms of GABAA receptor endocytosis and recycling.
Endocytosis by CCV requires AP2 and clathrin binding to the receptor. AP2
is specific for endocytosis of surface proteins and it consists of 4 subunits:
h, A, a, and j (Hirst & Robinson, 1998). First, h- and A-subunits of AP2recognize and bind to GABAA receptors, then clathrin binds the complex
and the receptor is internalized (see Section 4.3). Internalized receptors may
be recycled back to the cell surface or degraded depending upon undefined
intracellular signals. These signals appear to involve post-translational
modifications of receptors or associated proteins mediated by PKC. AP1
transports newly synthesized receptors from trans-Golgi reticulum to the
cell surface.
S. Kumar et al. / Pharmacology & Therapeutics 101 (2004) 211–226218
Internalization of GABAA receptors following chronic
ethanol administration is probably mediated by clathrin and
adaptor complex since the association of adaptin-a and
clathrin with a1-subunit-containing GABAA receptors in
the intracellular fraction was increased following chronic
ethanol administration (Kumar et al., 2003b). Recent studies
show that the dileucine motif found in h2-subunits of
GABAA receptors is required for recognition by the adaptor
complex-2 (AP2) that precedes clathrin-dependent endocy-
tosis (Herring et al., 2003). Therefore, it is possible that
PKC-mediated post-translational modification of GABAA
receptor subunits, receptor-associated proteins, and/or AP2
following chronic ethanol administration alters the recogni-
tion and endocytosis of GABAA receptors.
Recent studies have suggested that trafficking of GABAA
receptors can be regulated by PKC. Flunitrazepam-induced
reduction in expression of GABAA receptor a1-subunit is
prevented by PKC inhibitors in cultured cerebellar granule
cells (Johnston et al., 1998). Several studies in A293 cells
suggest that PKC activation leads to increased internaliza-
tion of a1h2g2 GABAA receptors (Connolly et al., 1999;
Cinar & Barnes, 2001). PKC may also play a role in
ethanol-induced changes in GABAA receptor trafficking.
Chronic ethanol consumption results in decreased associa-
tion of PKCg with a1-subunit-containing GABAA receptors
and decreased expression of a1-subunit at the cell surface.
In contrast, chronic ethanol exposure results in increased
association of PKCg with a4-subunit-containing GABAA
receptors and increased expression of a4 at the cell surface
(Kumar et al., 2002). Furthermore, in the hippocampus, the
association of PKCg with GABAA receptors is not altered
(Kumar et al., unpublished observation), and there is no
alteration of a1-subunit expression following chronic etha-
nol exposure (Matthews et al., 1998a; Morrow et al.,
2001a). Therefore, it appears that association of PKCg with
GABAA receptors may influence the trafficking (decreasing
internalization and/or increasing recycling) of receptors in
vivo following chronic ethanol administration. However, it
is still unknown whether PKCg phosphorylates GABAA
receptor subunits or associated proteins to alter trafficking
of receptors in vivo. Moreover, various isoforms of both
receptor and kinase are present in different levels in various
brain regions that complicate the interaction between recep-
tors and PKC. Therefore, region specific or cell-specific
effects of ethanol on GABAA receptors could be due to cell-
specific differences in interaction between the receptor and
receptor-associated signaling proteins, such as PKC.
Chronic ethanol consumption results in increased expres-
sion of a4, h2, and h3 GABAA receptor subunits in the
cerebral cortex and all contain consensus phosphorylation
sites for PKC (Wisden et al., 1991; Macdonald, 1995;
Mohler et al., 1996). In contrast, a1-, a2-, and a3-subunits
are decreased in the cortex and these subunits do not contain
consensus phosphorylation sites for PKC. The correlation
between the presence of PKC phosphorylation sites and
their increased cell surface expression following chronic
ethanol exposure could be a coincidence or it might indicate
that PKC regulates subunit expression. Differential expres-
sion of these subunits on the cell surface following chronic
ethanol exposure could be a result of selective PKC phos-
phorylation, endocytosis, and/or recycling. Other studies
have shown that threonine phosphorylation diverts internal-
ized epidermal growth factor receptors from degradative to
recycling pathways (Bao et al., 2000). Thus, differential
effects of ethanol on the association of PKCg with these
receptors and phosphorylation may influence endocytosis
and/or recycling of these receptors in vivo. We have recently
detected PKCg and PKCq peptides in the CCV fraction of
the cerebral cortex (Fig. 4). Furthermore, chronic ethanol
exposure increases PKCq peptide levels while PKCg levels
remain unchanged in CCV fraction (Fig. 4). However, the
functional significance of these findings remains to be
established.
4.4. Synaptic localization of receptors
Application of GABAA agonist in most pharmacological
studies activates both synaptic and extrasynaptic receptors.
However, synaptic and extrasynaptic receptors are thought
to play different roles in the regulation of neuronal excit-
ability. Some studies have shown that the a1-subunit is
usually expressed in synaptic GABAA receptors while the
a4-subunit predominantly occurs in extrasynaptic receptors
(Mody, 2001). GABAA receptors containing a1- and a4-
subunits have different pharmacological characteristics, in-
Fig. 4. Chronic ethanol administration increases peptide levels of PKCq but not of PKCg in the CCV fraction of cerebral cortex. Ethanol was administered to
rats as described in Fig. 2. Animals were sacrificed on day 15 and cerebral cortex was dissected and stored at � 80 jC. The CCV fraction was isolated (Kumar
et al., 2003b), analyzed by western blot analysis, and probed using anti-PKCg, PKCq, and h-actin antibodies. Representative western blot analysis showing (A)PKCq and (B) PKCg peptides in the CCV fraction of cerebral cortex from control (lane 1) and ethanol-dependent (lane 2) rats. Peptides levels of PKCq andPKCg were normalized to h-actin for equal gel loading and transfer. Chronic ethanol administration (A) increased the peptide levels of PKCq by 47.44 F18.5% ( P < 0.05, n = 5) in the CCV fraction while (B) peptides levels of PKCg were not altered (n = 5). Each independent experiment was conducted in
duplicate using CCV fractions prepared from pooled cerebral cortices of 8 rats per group.
S. Kumar et al. / Pharmacology & Therapeutics 101 (2004) 211–226 219
cluding different sensitivities to zolpidem, Ro15-4513, flu-
mazenil, and bretanzenil (Wafford et al., 1996; Whittemore
et al., 1996). Ethanol has been shown to alter GABAergic
synaptic transmission in both the hippocampus (Weiner et
al., 1994) and the amygdala (Roberto et al., 2003). Chronic
ethanol exposure in vivo has been shown to alter the
function of GABAA receptors measured by Cl� flux in
synaptoneurosomes and single-unit recording (Grobin et al.,
1998). However, neither Cl � flux assays nor assays of
single-unit activity in vivo can discriminate between
changes in synaptic versus extrasynaptic GABAA receptor
function. To date, only one study has specifically addressed
the effects of chronic ethanol exposure on synaptic GABAA
receptors by investigation of miniature inhibitory postsyn-
aptic current (mIPSC). mIPSC are postsynaptic currents that
occur in response to spontaneous fusion of a single vesicle
of GABA. Because the synaptic machinery precisely con-
trols the application and removal of agonist, changes in the
kinetics of the postsynaptic receptor response to GABA are
reflected in the changes in the shape of the mIPSC. Cagetti
et al. (2003) found changes in synaptic GABAA receptor
function in the hippocampus of rats that had undergone CIE
treatment followed by 2 days of withdrawal. CIE treatment
decreased the frequency, rise time, amplitude, and decay
time of mIPSCs in pyramidal neurons from CA1, an overall
change in GABAA receptor function that is consistent with
increased neuronal excitability. Interestingly, CIE eliminated
the effects of diazepam on the mIPSC and increased mIPSC
sensitivity to the a4-subunit-selective benzodiazepine Ro15-
4513. These pharmacological changes are consistent with a
decreased expression of the a1-subunit-containing (type 1)
receptors and an increased expression of the a4-subunit-
containing receptors in the synapse. In another study, Hsu et
al. (2003) demonstrated that brief (48- to 72-hr) exposure to
the neurosteroid 3a,5a-THP decreases the decay time of
mIPSCs recorded in hippocampal CA1 pyramidal cells.
mIPSCs from 3a,5a-THP-treated rats were also insensitive
to diazepam and more sensitive to Ro15-4513. The decrease
in mIPSC decay time was blocked by infusion of a4-subunit
antisense oligonucleotides into the hippocampus, suggesting
that this change in synaptic GABAA receptor kinetics is due
to an increase in synaptic a4-subunit expression. Taken
together, these studies suggest that translocation of a4-
subunit receptors from an extrasynaptic to synaptic locali-
zation may represent a mechanism of GABAA receptor
adaptation to both ethanol and neurosteroid exposure. Since
systemic ethanol administration increases GABAergic neu-
rosteroid concentrations in brain (Morrow et al., 1999;
VanDoren et al., 2000; Morrow et al., 2003), this adaptation
to ethanol may involve a neurosteroid intermediary.
4.5. Regulation of c-aminobutyric acidA receptors
by other receptors via intracellular signaling systems
As our understanding of cellular signaling pathways has
advanced, it has become increasingly apparent that, intracel-
lular signal transduction pathways are activated by many
postsynaptic receptors that, in turn, alter the function of other
postsynaptic receptors. Furthermore, it is known that differ-
ent intracellular signal transduction pathways can interact
through the mutual regulation of kinases and phosphatases to
provide an additional layer of complexity to their regulation
(Dombradi et al., 2002). Intracellular communication be-
tween receptors is critical for the coordinated function of
cells. The cross-talk between receptors might result from
intracellular signaling pathways involving inositol triphos-
S. Kumar et al. / Pharmacology & Therapeutics 101 (2004) 211–226220
phate (IP3), Ca2+ , PKC, PKA, and/or protein phosphatases.
There are several examples of interactions among muscarinic
acetylcholine (mACh), N-methyl-D-aspartate (NMDA), se-
rotonin (5-HT), and h-adrenergic receptors with GABAA
receptors. For example, mACh receptor activation decreases
GABA-mediated currents in cultured superior cervical gan-
glion neurons, and this effect is blocked by PKC inhibitors
(Brandon et al., 2002). Furthermore, chronic ethanol admin-
istration alters the function and/or expression of many of the
receptors and kinases involved in cross-talk with GABAA
receptors. Therefore, it is essential to understand the inter-
actions of GABAA receptors with other receptors for a clear
understanding of GABAA receptor adaptations following
chronic ethanol administration.
Chronic ethanol exposure up-regulates NMDA receptor
function and down-regulates GABAA receptor function (see
Crews et al., 1996, for a review). Since many neurons
contain both NMDA and GABAA receptors and ethanol
modulates both NMDA and GABAA receptors, interactions
between these receptors may play an important role in
GABAA receptor adaptation following ethanol administra-
tion. For example, MK-801 administration to rats, like
ethanol, increases the membrane expression of GABAA
receptor a4-subunits in the hippocampus (Matthews et al.,
1998b). The effect on GABAA receptors following NMDA
receptor activation is mediated by intracellular Ca2+ , since
the Ca2+ chelator (BAPTA) blocks the down-regulation of
GABAA receptors following NMDA receptor activation
(Robello et al., 1997). In addition, the application of
glutamate in hippocampal cultures leads to translocation
of PKCa and g to the plasma membrane and cytoplasmic
organelles, respectively, while PKCq localization remains
unaltered (Etoh et al., 1991; Buchner et al., 1999). There-
fore, interactions of NMDA and GABAA receptors via
intracellular signaling pathways may play a vital role in
GABAA receptor adaptation following chronic ethanol
administration. In addition, both NMDA and GABAA
receptor activation, as well as ethanol administration alter
brain-derived neurotrophic factor (BDNF) expression in
neurons (Zafra et al., 1991; MacLennan et al., 1995;
Tapia-Arancibia et al., 2001; Obrietan et al., 2002). BDNF
has been shown to alter GABAA receptor function and
expression. For example, addition of BDNF in cortical cell
cultures increases phosphorylation of GABAA receptor h3-
subunits (Jovanovic et al., 2000) and increases internaliza-
tion of GABAA receptor a2-, h2/3-, and g2-subunits (Brunig
et al., 2001). In contrast, chronic application of BDNF
increases expression of GABAA receptor a6-subunit in
cerebellar granular cells that is blocked by concomitant
application of ethanol (Ericson et al., 2003). Therefore, it is
possible that ethanol-induced altered trafficking and ex-
pression of GABAA receptors are partially mediated by
BDNF. Future studies on interactions of BDNF and
GABAA receptor following chronic ethanol exposure are
needed to clarify the role of BDNF on ethanol-induced
adaptation of GABAA receptors.
Likewise, 5-HT receptors can modulate GABAA receptor
function and expression via PKC-mediated pathways. Acti-
vation of 5-HT2 receptor results in inhibition of GABAA
receptor-mediated currents that can be blocked by the Ca2 +
chelator (BAPTA) and the RACK inhibitory peptide
(RACKI-rVI) (Feng et al., 2001). In addition, 5-HT1A
receptor knock-out mice exhibit down-regulation of
GABAA receptor a2-subunit mRNA levels and up-regula-
tion of a1-subunit mRNAs in both the cortex and the
amygdala, while a4-subunit mRNAs are decreased in the
hippocampus (Sibille et al., 2000). Hence, it is clear that
activation of 5-HT receptors can alter GABAA receptor
function and expression. In addition, recent studies have
concluded that dopamine and h-adrenergic (Flores-Hernan-
dez et al., 2000) receptors can also modulate GABAA
receptors via PKA-mediated pathways. Taken together, it
is obvious that receptor cross-talk plays a vital role in
modulation of GABAA receptor function and expression.
Therefore, a clear understanding of these interactions be-
tween receptors is critical for understanding the mechanisms
that underlie ethanol tolerance and dependence.
4.6. Role of neurosteroids in ethanol tolerance and
dependence
Ethanol tolerance results in a reduction in the anxiolytic,
motor-incoordinating, and sedative-hypnotic effects of eth-
anol and a requirement for higher ethanol doses to elicit
pharmacologic effects (Boisse & Okamoto, 1980; Le et al.,
1986; Brown et al., 1988). There is some evidence indicat-
ing that alterations in the effects of ethanol on neurosteroid
levels may play a role in the development or maintenance of
ethanol tolerance. Although acute systemic ethanol admin-
istration elevates 3a,5a-THP levels in the brain, chronic
ethanol consumption does not alter steady-state 3a,5a-THP
levels (Janis et al., 1998). Indeed, ethanol-dependent male
rats show decreased levels of 3a,5a-THP in the cerebral
cortex as compared with pair-fed controls, while ethanol-
withdrawn animals showed a return of cortical 3a,5a-THP
to baseline levels (Janis et al., 1998). Furthermore, ethanol-
dependent and -withdrawn animals given a moderate etha-
nol challenge showed reduced levels of ethanol-induced
3a,5a-THP in the cerebral cortex as compared with etha-
nol-naive rats (Morrow et al., 2001b). Hence, tolerance to
ethanol may involve a loss of the ability of ethanol to
increase 3a,5a-THP levels and a corresponding reduction in
related pharmacological effects of ethanol. The loss of the
neurosteroid response to ethanol may contribute to the
changes in GABAA receptor function, expression, and
subcellular localization that are associated with the devel-
opment of ethanol tolerance (Grobin et al., 1998). There-
fore, the interplay of the neuromodulating and genomic
effects of 3a,5a-THP may play a key role in adaptations
to ethanol.
Changes in the sensitivity to neurosteroids are also
associated with the development of ethanol dependence.
S. Kumar et al. / Pharmacology & Therapeutics 101 (2004) 211–226 221
Administration of 3a,5a-THP blocks the decrease in bicu-
culline-induced seizure threshold seen in ethanol-withdrawn
rats at doses of 3a,5a-THP that do not increase seizure
threshold in pair-fed control rats (Devaud et al., 1995a).
Indeed, there is a dramatic sensitization to the anticonvul-
sant effects of 3a,5a-THP and 3a,5a-THDOC in ethanol-
dependent rats (Devaud et al., 1996, 1998). This behavioral
sensitization to neurosteroids is accompanied by an increase
in sensitivity of GABAA receptors to 3a,5a-THP and
3a,5a-THDOC in cerebral cortical synaptoneurosomes us-
ing a Cl � flux assay (Devaud et al., 1996) and is not due to
different endogenous levels of 3a,5a-THP in withdrawn
versus control rats (Janis et al., 1998). Furthermore, neuro-
steroid sensitization during withdrawal is accompanied by
an increase in GABAA receptor a4-, g1-, h2-, and h3-subunit
mRNA and peptides. These subunits have been shown to
maintain or increase sensitivity of GABAA receptors to
neurosteroid in recombinant expression systems (Puia et
al., 1990, 1991).
The relationship between neurosteroid levels and the
sensitivity of GABAA receptors to neurosteroids in etha-
nol-dependent rats remains controversial. Although one
study found no change in endogenous 3a,5a-THP levels
in the cortex or plasma of ethanol-withdrawn rats (Janis et
al., 1998), other studies have reported decreases in neuro-
steroid levels in ethanol-withdrawing mice and humans.
Plasma 3a,5a-THP levels were decreased in ethanol-with-
drawn B6 and D2 mice, relative to controls (Finn et al.,
2000). Interestingly, the B6 mice showed a decrease in
3a,5a-THP levels of 15%, whereas there was a 50%
decrease in D2 mice. The greater reduction in endogenous
neurosteroid in withdrawn D2 mice could contribute to the
greater withdrawal severity experienced by those animals. In
alcoholics, decreased levels of both 3a,5a-THP and 3a,5a-
THDOC have been reported during the early phase of
ethanol withdrawal (Romeo et al., 1996). This early phase
of ethanol withdrawal is characterized by increases in
anxiety and depression that can be measured by psycholog-
ical tests. Later in withdrawal, when the anxiety and
depression disappear, neurosteroid levels also return to
normal. This study suggests that reduced levels of endog-
enous GABAergic neurosteroids contribute to the negative
consequences of ethanol withdrawal.
Withdrawal from progesterone and associated decreases
in 3a,5a-THP result in behavioral changes that mimic the
signs of ethanol withdrawal. Specifically, progesterone-
withdrawn female rats exhibit increased anxiety (Gallo &
Smith, 1993), increased sensitivity to convulsant drugs that
act on GABAA receptors (Smith et al., 1998a), and de-
creased sensitivity to the sedative effects of benzodiazepines
(Moran & Smith, 1998). Whole-cell patch clamp electro-
physiology in dissociated neurons from CA1 of the hippo-
campus showed that the behavioral changes were
accompanied by changes in the function of GABAA recep-
tors associated with increases in a4-subunit peptide and
mRNA during progesterone withdrawal (Smith et al., 1998a,
1998b). Furthermore, blocking this increase by infusion of
antisense a4 oligonucleotides into the hippocampus during
progesterone withdrawal eliminates the increase in seizure
sensitivity (Smith et al., 1998a), behavioral tolerance to
benzodiazepines (Moran et al., 1998), and the change in
electrophysiological properties of GABAA receptors (Smith
et al., 1998a). Therefore, in this model, it seems that
withdrawal from exposure to progesterone and 3a,5a-THP
causes a change in GABAA receptor subunit expression that
results in the changes in GABAA receptor function that are
responsible for the behavioral signs of withdrawal.
Ethanol- and progesterone-withdrawing animals exhibit
similar withdrawal signs, such as increased anxiety, in-
creased seizure susceptibility, and decreased sensitivity to
benzodiazepines. These changes occur at the same time as
increases in a4-subunit mRNA (Devaud et al., 1995b) and
peptide levels (Devaud et al., 1997) in the cerebral cortices
and hippocampus (Cagetti et al., 2003) of ethanol-dependent
rats. These adaptations are associated with alterations in
GABAA receptor function, including reduced sensitivity to
GABA and benzodiazepines and increased sensitivity to
inverse agonists (Table 2). Therefore, it is possible that
changes in endogenous neurosteroid levels that occur during
chronic ethanol exposure and/or withdrawal contribute to
the changes in GABAA receptor function that underlie
ethanol dependence. However, ethanol withdrawal is asso-
ciated with different changes in GABAA receptor expression
and function that were not reported following progesterone
withdrawal, including changes in a1–3-, h2/3-, and g1–2-
subunit expression and sensitization to 3a,5a-THP (Devaud
et al., 1996, 1997). Moreover, ethanol-dependent and with-
drawn animals are tolerant to ethanol, and progesterone-
withdrawn rats are more sensitive to ethanol (Sundstrom-
Poromaa et al., 2002). Therefore, further studies are needed
to determine the role of neurosteroids in ethanol-induced
adaptations of GABAA receptors.
5. Conclusions
Recent studies have clearly demonstrated that adapta-
tions in GABAA receptors play an important role in ethanol
dependence. However, the exact mechanisms that account
for alterations in GABAA receptor function following
chronic ethanol administration have not been resolved.
The molecular determinants of these alterations in GABAA
receptor function are complex, probably due to the hetero-
geneity of GABAA receptor subtypes and the diversity of
biochemical mechanisms that regulate the function of these
receptors. GABAA receptors are a primary target for the
actions of ethanol in the brain. Chronic ethanol administra-
tion consistently alters the mRNA levels and membrane
expression of various GABAA receptor subunits, suggesting
that alterations in GABAA receptor expression may account
for alterations in GABAA receptor function. In addition,
chronic ethanol can modulate GABAA receptor functions by
S. Kumar et al. / Pharmacology & Therapeutics 101 (2004) 211–226222
altering post-transcriptional modifications of receptor sub-
units, subcellular localization of receptors, and/or interac-
tions with other neurotransmitter systems. Endogenous
regulators like neurosteroids and signaling proteins also
play a role in modulating GABAA receptor function follow-
ing chronic ethanol administration. Therefore, it is likely
that multiple mechanisms are responsible for adaptation of
GABAA receptors following chronic ethanol exposure.
Acute ethanol administration potentiates GABA-mediat-
ed inhibition both in vitro and in vivo, but does not alter
GABAA receptor subunit expression. Hence, the effect of
acute ethanol exposure on GABAA receptors is probably
primarily due to intracellular signaling systems that may
include neurosteroids and/or post-translational receptor
modifications. Since post-translational modification is a
short-lived effect, receptors can revert to normal immedi-
ately and the whole process requires less energy and time
compared with long-lasting changes in subunit expression
following prolonged ethanol exposure. Prolonged ethanol
exposure results in long-lasting changes in GABAA receptor
subunit expression on the cell surface that could be due to
altered receptor trafficking, subcellular or synaptic localiza-
tion of receptors, altered steroid responses to ethanol, and
possibly altered composition of GABAA receptors. These
changes clearly involve intracellular signaling cascades,
although the exact sequence of adaptations is yet unknown.
Taken together, it is clear that ethanol regulates GABAA
receptor function via both genomic and nongenomic mech-
anisms that interact to produce the complex adaptations in
brain resulting in tolerance and dependence upon ethanol.
Acknowledgments
This work was supported by NIH grants AA 11605 and
AA 09013. We thank Brooke Schwildwacter and Todd
O’Buckley for excellent laboratory assistance.
References
Aguayo, L. G., Pancetti, F. C., Klein, R. L., & Harris, R. A. (1994).
Differential effects of GABAergic ligands in mouse and rat hippocam-
pal neurons. Brain Res 647, 97–105.
Allan, A. M., & Harris, R. A. (1987). Acute and chronic ethanol treatments
alter GABA receptor-operated chloride channels. Pharmacol Biochem
Behav 27, 665–670.
Bao, J., Alroy, I., Waterman, H., Schejter, E. D., Brodie, C., Gruenberg, J.,
& Yarden, Y. (2000). Threonine phosphorylation diverts internalized
epidermal growth factor receptors from a degradative pathway to the
recycling endosome. J Biol Chem 275, 26178–26186.
Barbaccia, M. L., Affricano, D., Trabucchi, M., Purdy, R. H., Colombo, G.,
Agabio, R., & Gessa, G. L. (1999). Ethanol markedly increases
‘‘GABAergic’’ neurosteroids in alcohol-preferring rats. Eur J Pharma-
col 384, R1–R2.
Barmack, N. H., Qian, Z., & Yoshimura, J. (2000). Regional and cellular
distribution of protein kinase C in rat cerebellar Purkinje cells. J Comp
Neurol 427, 235–254.
Bencsits, E., Ebert, V., Tretter, V., & Sieghart, W. (1999). A significant
part of native gamma-aminobutyric acidA receptors containing alpha4
subunits do not contain gamma or delta subunits. J Biol Chem 274,
19613–19616.
Boisse, N. N., & Okamoto, M. (1980). Ethanol as a sedative-hypnotic:
comparison with barbiturate and non-barbiturate sedative-hypnotics.
In H. Rigter, & J. C. Crabbe (Eds.), Alcohol Tolerance and Dependence
( pp. 265–292). Amsterdam: Elsevier.
Bowers, B. J., Elliott, K. J., & Wehner, J. M. (2001). Differential sensitivity
to the anxiolytic effects of ethanol and flunitrazepam in PKCgamma
null mutant mice. Pharmacol Biochem Behav 69, 99–110.
Brandon, N. J., Uren, J. M., Kittler, J. T., Wang, H., Olsen, R., Parker, P.
J., & Moss, S. J. (1999). Subunit specific association of protein kinase
C and the receptor for activated C kinase with GABA type A receptors.
J Neurosci 19, 9228–9234.
Brandon, N. J., Delmas, P., Kittler, J. T., McDonald, B. J., Sieghart, W.,
Brown, D. A., Smart, T. G., & Moss, S. J. (2000). GABAA receptor
phosphorylation and functional modulation in cortical neurons by a
protein kinase C-dependent pathway. J Biol Chem 275, 38856–38862.
Brandon, N. J., Jovanovic, J. N., Smart, T. G., & Moss, S. J. (2002).
Receptor for activated C kinase-1 facilitates protein kinase C-depen-
dent phosphorylation and functional modulation of GABA(A) recep-
tors with the activation of G-protein-coupled receptors. J Neurosci 22,
6353–6361.
Brandon, N. J., Jovanovic, J. N., Colledge, M., Kittler, J. T., Brandon, J. M.,
Scott, J. D., & Moss, S. J. (2003). A-kinase anchoring protein 79/150
facilitates the phosphorylation of GABA(A) receptors by cAMP-depen-
dent protein kinase via selective interaction with receptor beta subunits.
Mol Cell Neurosci 22, 87–97.
Brown, M. E., Anton, R. F., Malcolm, R., & Ballenger, J. C. (1988).
Alcohol detoxification and withdrawal seizures: clinical support for a
kindling hypothesis. Biol Psychiatry 23, 507–514.
Brunig, I., Penschuck, S., Berninger, B., Benson, J., & Fritschy, J. M.
(2001). BDNF reduces miniature inhibitory postsynaptic currents by
rapid downregulation of GABAA receptor surface expression. Eur J
Neurosci 13, 1320–1328.
Buchner, K., Adamec, E., Beermann, M. L., & Nixon, R. A. (1999). Iso-
form-specific translocation of protein kinase C following glutamate
administration in primary hippocampal neurons. Brain Res Mol Brain
Res 64, 222–235.
Buck, K. J., & Harris, R. A. (1990). Benzodiazepine agonist and inverse
agonist actions on GABAA receptor-operated chloride channels: II.
Chronic effects of ethanol. J Pharmacol Exp Ther 253, 713–719.
Cagetti, E., Liang, J., Spigelman, I., & Olsen, R. W. (2003). Withdrawal
from chronic intermittent ethanol treatment changes subunit composi-
tion, reduces synaptic function, and decreases behavioral responses to
positive allosteric modulators of GABAA receptors. Mol Pharmacol 63,
53–64.
Celentano, J. J., Gibbs, T. T., & Farb, D. H. (1988). Ethanol potentiates
GABA- and glycine-induced chloride currents in chick spinal cord
neurons. Brain Res 455, 377–380.
Chapell, R., Bueno, O. F., Alvarez-Hernandez, X., Robinson, L. C., &
Leidenheimer, N. J. (1998). Activation of protein kinase C induces
gamma-aminobutyric acid type A receptor internalization in Xenopus
oocytes. J Biol Chem 273, 32595–32601.
Chen, L., Wang, H., Vicini, S., & Olsen, R. W. (2000). The gamma-amino-
butyric acid type A (GABAA) receptor-associated protein (GABARAP)
promotes GABAA receptor clustering and modulates the channel kinet-
ics. Proc Natl Acad Sci USA 97, 11557–11562.
Churn, S. B., & DeLorenzo, R. J. (1998). Modulation of GABAergic re-
ceptor binding by activation of calcium and calmodulin-dependent ki-
nase II membrane phosphorylation. Brain Res 809, 68–76.
Churn, S. B., Rana, A., Lee, K., Parsons, J. T., De Blas, A., & Delorenzo,
R. J. (2002). Calcium/calmodulin-dependent kinase II phosphorylation
of the GABAA receptor alpha1 subunit modulates benzodiazepine bind-
ing. J Neurochem 82, 1065–1076.
Cinar, H., & Barnes Jr., E. M. (2001). Clathrin-independent endocytosis of
GABA(A) receptors in HEK 293 cells. Biochemistry 40, 14030–14036.
S. Kumar et al. / Pharmacology & Therapeutics 101 (2004) 211–226 223
Connolly, C. N., Kittler, J. T., Thomas, P., Uren, J. M., Brandon, N. J.,
Smart, T. G., & Moss, S. J. (1999). Cell surface stability of gam-
ma-aminobutyric acid type A receptors: dependence on protein
kinase C activity and subunit composition. J Biol Chem 274,
36565–36572.
Crews, F., Morrow, A. L., Criswell, H., & Breese, G. (1996). Effects of
ethanol on ion channels. In R. J. Bradley, & R. A. Harris (Eds.), Inter-
national Review of Neurobiology, vol. 39 (pp. 283–367). New York:
Academic Press.
Criswell, H. E., Simson, P. E., Johnson, K. B., & Breese, G. R. (1993).
Chronic ethanol decreases the ability of GABA to inhibit ethanol-sen-
sitive neurons in the medial septum. Alcohol Clin Exp Res 17, 477.
Devaud, L. L., Purdy, R. H., & Morrow, A. L. (1995a). The neurosteroid,
3a-hydroxy-5a-pregnan-20-one, protects against bicuculline-induced
seizures during ethanol withdrawal in rats. Alcohol Clin Exp Res 19,
350–355.
Devaud, L. L., Smith, F. D., Grayson, D. R., & Morrow, A. L. (1995b).
Chronic ethanol consumption differentially alters the expression of g-
aminobutyric acid type A receptor subunit mRNAs in rat cerebral cor-
tex: competitive, quantitative reverse transcriptase-polymerase chain
reaction analysis. Mol Pharmacol 48, 861–868.
Devaud, L. L., Purdy, R. H., Finn, D. A., & Morrow, A. L. (1996). Sen-
sitization of g-aminobutyric acidA receptors to neuroactive steroids in
rats during ethanol withdrawal. J Pharmacol Exp Ther 278, 510–517.
Devaud, L. L., Fritschy, J. -M., Sieghart, W., & Morrow, A. L. (1997).
Bidirectional alterations of GABAA receptor subunit peptide levels in
rat cortex during chronic ethanol consumption and withdrawal. J Neuro-
chem 69, 126–130.
Devaud, L. L., Fritschy, J. -M., & Morrow, A. L. (1998). Influence of
gender on chronic ethanol-induced alternations of GABAA receptors
in rats. Brain Res 796, 222–230.
Dohrman, D. P., Chen, H. M., Gordon, A. S., & Diamond, I. (2002).
Ethanol-induced translocation of protein kinase A occurs in two phases:
control by different molecular mechanisms. Alcohol Clin Exp Res 26,
407–415.
Dombradi, V., Krieglstein, J., & Klumpp, S. (2002). Regulating the regu-
lators. Conference on protein phosphorylation and protein phospha-
tases. EMBO Rep 3, 120–124.
Ericson, M., Haythornthwaite, A. R., Yeh, P. W., & Yeh, H. H. (2003).
Brain-derived neurotrophic factor mitigates chronic ethanol-induced at-
tenuation of gamma-aminobutyric acid responses in cultured cerebellar
granule cells. J Neurosci Res 73, 722–730.
Etoh, S., Baba, A., & Iwata, H. (1991). NMDA induces protein kinase C
translocation in hippocampal slices of immature rat brain. Neurosci Lett
126, 119–122.
Fancsik, A., Linn, D. M., & Tasker, J. G. (2000). Neurosteroid modula-
tion of GABA IPSCs is phosphorylation dependent. J Neurosci 20,
3067–3075.
Feng, J., Cai, X., Zhao, J., & Yan, Z. (2001). Serotonin receptors modulate
GABA(A) receptor channels through activation of anchored protein
kinase C in prefrontal cortical neurons. J Neurosci 21, 6502–6511.
Finn, D. A., Gallaher, E. J., & Crabbe, J. C. (2000). Differential change in
neuroactive steroid sensitivity during ethanol withdrawal. J Pharmacol
Exp Ther 292, 394–405.
Flores-Hernandez, J., Hernandez, S., Snyder, G. L., Yan, Z., Fienberg,
A. A., Moss, S. J., Greengard, P., & Surmeier, D. J. (2000). D(1)
dopamine receptor activation reduces GABA(A) receptor currents in
neostriatal neurons through a PKA/DARPP-32/PP1 signaling cas-
cade. J Neurophysiol 83, 2996–3004.
Freund, R. K., & Palmer, M. R. (1997). Beta adrenergic sensitization of
gamma-aminobutyric acid receptors to ethanol involves a cyclic AMP/
protein kinase A second-messenger mechanism. J Pharmacol Exp Ther
280, 1192–1200.
Frye, G. D., Chapin, R. E., Vogel, R. A., Mailman, R. B., Kilts, C. D.,
Mueller, R. A., & Breese, G. R. (1981). Effects of acute and chronic
1,3-butanediol treatment on central nervous system function: a compar-
ison with ethanol. J Pharmacol Exp Ther 216, 306–314.
Frye, G. D., Mathew, J., & Trezciakowski, J. (1993). Effect of ethanol
dependence on GABAA antagonist-induced seizures and agonist-stim-
ulated chloride uptake. Alcohol 8, 453–459.
Frye, G. D., Fincher, A. S., Grover, C. A., & Griffith, W. H. (1994).
Interaction of ethanol and allosteric modulators with GABAA-activated
currents in adult medial septum/diagonal band neurons. Brain Res 635,
283–292.
Gallo, M. A., & Smith, S. S. (1993). Progesterone withdrawal decreases
latency to and increases duration of electrified prod burial: a possible rat
model of PMS anxiety. Pharmacol Biochem Behav 46, 897–904.
Ghansah, E., & Weiss, D. S. (2001). Modulation of GABA(A) receptors by
benzodiazepines and barbiturates is autonomous of PKC activation.
Neuropharmacology 40, 327–333.
Givens, B. S., & Breese, G. R. (1990). Site-specific enhancement of g-
aminobutyric acid-mediated inhibition of neural activity by ethanol in
the rat medial septum. J Pharmacol Exp Ther 254, 528–538.
Givens, B. S., & McMahon, K. (1997). Effects of ethanol on nonspatial
working memory and attention in rats. Behav Neurosci 111, 275–282.
Gonzalez, L. P., & Czachura, J. F. (1989). Reduced behavioral responses to
intranigral muscimol following chronic ethanol. Physiol Behav 46,
473–477.
Grobin, A. C., Matthews, D. B., Devaud, L. L., & Morrow, A. L. (1998).
The role of GABAA receptors in the acute and chronic effects of eth-
anol. Psychopharmacology 139, 2–19.
Grobin, A. C., Fritschy, J. -M., & Morrow, A. L. (2000). Chronic ethanol
administration alters immunoreactivity for GABAA receptor subunits
in rat cortex in a region-specific manner. Alcohol Clin Exp Res 24,
1137–1144.
Harris, R. A., McQuilkin, S. J., Paylor, R., Abeliovich, A., Tonegawa, S., &
Wehner, J. M. (1995). Mutant mice lacking the gamma isoform of
protein kinase C show decreased behavioral actions of ethanol and
altered functions of gamma-aminobutyrate type A receptors. Proc Natl
Acad Sci USA 92, 3658–3662.
Harris, R. A., Mihic, S. J., & Valenzuela, C. F. (1998). Alcohol and
benzodiazepines: recent mechanistic studies. Drug Alcohol Depend
51, 155–164.
Herring, D., Huang, R., Singh, M., Robinson, L. C., Dillon, G. H., &
Leidenheimer, N. J. (2003). Constitutive GABAA receptor endocytosis
is dynamin-mediated and dependent on a dileucine AP2 adaptin-bind-
ing motif within the h2 subunit of the receptor. J Biol Chem 278,
24046–24052.
Heuschneider, G., & Schwartz, R. D. (1989). cAMP and forskolin decrease
g-aminobutyric acid-gated chloride flux in rat brain synaptoneuro-
somes. Proc Natl Acad Sci USA 86, 2938–2942.
Hirst, J., & Robinson, M. S. (1998). Clathrin and adaptors. Biochim Bio-
phys Acta 1404, 173–193.
Hodge, C. W., Mehmert, K. K., Kelley, S. P., McMahon, T., Haywood, A.,
Olive, M. F., Wang, D., Sanchez-Perez, A. M., & Messing, R. O.
(1999). Supersensitivity to allosteric GABAA receptor modulators and
alcohol in mice lacking PKCq. Nat Neurosci 2, 997–1002.Hsu, F. C., Waldeck, R., Faber, D. S., & Smith, S. S. (2003). Neurosteroid
effects on GABAergic synaptic plasticity in hippocampus. J Neurophy-
siol 89, 1929–1940.
Huang, R. Q., & Dillon, G. H. (1998). Maintenance of recombinant type A
gamma-aminobutyric acid receptor function: role of protein tyrosine
phosphorylation and calcineurin. J Pharmacol Exp Ther 286, 243–255.
Janis, G. C., Devaud, L. L., Mitsuyama, H., & Morrow, A. L. (1998).
Effects of chronic ethanol consumption and withdrawal on the neuro-
active steroid 3a-hydroxy-5a-pregnan-20-one in male and female rats.
Alcohol Clin Exp Res 22, 2055–2061.
Johnston, J. D., Price, S. A., & Bristow, D. R. (1998). Flunitrazepam
rapidly reduces GABAA receptor subunit protein expression via a
protein kinase C-dependent mechanism. Br J Pharmacol 124,
1338–1340.
Jovanovic, J. N., Kittler, J. T., Brandon, N. J., & Moss, S. J. (2000).
Characterization of the specificity in situ of the phosphorylation state-
specific antibody for GABAA receptor beta3 subunit (Program Number
S. Kumar et al. / Pharmacology & Therapeutics 101 (2004) 211–226224
522.1). 2000 Abstract Viewer/Itinerary Planner. Washington, DC:
Society for Neuroscience.
Kang, M. H., Spigelman, I., & Olsen, R. W. (1998). Alteration in the
sensitivity of GABAA receptors to allosteric modulatory drugs in rat
hippocampus after chronic intermittent ethanol treatment. Alcohol Clin
Exp Res 22, 2165–2173.
Kannenberg, K., Schaerer, M. T., Fuchs, K., Sieghart, W., & Sigel, E.
(1999). A novel serine kinase with specificity for h3-subunits is tightlyassociated with GABAA receptors. J Biol Chem 274, 21257–21264.
Kano, M., & Konnerth, A. (1992). Potentiation of GABA-mediated currents
by cAMP-dependent protein kinase. NeuroReport 3, 563–566.
Kano, M., Rexhausen, U., Dreessen, J., & Konnerth, A. (1992). Synaptic
excitation produces a long-lasting rebound potentiation of inhibitory
synaptic signals in cerebellar Purkinje cells. Nature 356, 601–604.
Kellenberger, S., Malherbe, P., & Sigel, E. (1992). Function of the a1h2g2sg-aminobutyric acid typeA receptor is modulated by protein kinase C
via multiple phosphorylation sites. J Biol Chem 267, 25660–25663.
Kikkawa, U., Kishimoto, A., & Nishizuka, Y. (1989). The protein kinase C
family: heterogeneity and its implications.AnnuRev Biochem58, 31–44.
Kittler, J. T., Delmas, P., Jovanovic, J. N., Brown, D. A., Smart, T. G., &
Moss, S. J. (2000). Constitutive endocytosis of GABAA receptors by an
association with the adaptin AP2 complex modulates inhibitory synap-
tic currents in hippocampal neurons. J Neurosci 20, 7972–7977.
Klein, R. L., Mascia, M. P., Whiting, P. J., & Harris, R. A. (1995). GABAA
receptor function and binding in stably transfected cells: chronic ethanol
treatment. Alcohol Clin Exp Res 19, 1338–1344.
Kralic, J. E., Korpi, E. R., O’Buckley, T. K., Homanics, G. E., & Morrow,
A. L. (2002a). Molecular and pharmacological characterization of
GABAA receptor a1 subunit knockout mice. J Pharmacol Exp Ther
302, 1037–1045.
Kralic, J. E., O’Buckley, T. K., Khisti, R. T., Hodge, C. W., Homanics,
G. E., & Morrow, A. L. (2002b). GABAA receptor a1 subunit
deletion alters receptor subtype assembly, pharmacological and be-
havioral responses to benzodiazepines and zolpidem. Neuropharma-
cology 43, 685–694.
Krishek, B. J., Xie, X., Blackstone, C., Huganir, R. L., Moss, S. J., &
Smart, T. G. (1994). Regulation of GABAA receptor function by protein
kinase C phosphorylation. Neuron 12, 1081–1095.
Kumar, S., Sieghart, W., & Morrow, A. L. (2002). Association of protein
kinase C with GABAA receptors containing a1 and a4 subunits in the
cerebral cortex: selective effects of chronic ethanol consumption.
J Neurochem 82, 110–117.
Kumar, S., Khisti, R. T., & Morrow, A. L. (2003a). PKC activity reduces
muscimol-stimulated 36Cl� uptake in cerebral cortical synaptoneuro-
somes and modulates the hypnotic effect of muscimol in rats (Program
Number 569.1). 2003 Abstract Viewer/Itinerary Planner. Washington,
DC: Society for Neuroscience.
Kumar, S., Kralic, J. E., O’Buckley, T. K., Grobin, A. C., & Morrow, A. L.
(2003b). Chronic ethanol consumption enhances internalization of al-
pha1 subunit-containing GABAA receptors in cerebral cortex. J Neuro-
chem 86, 700–708.
Le, A. D., Khanna, J. M., Kalant, H., & Grossi, F. (1986). Tolerance to and
cross-tolerance among ethanol, pentobarbital and chlordiazepoxide.
Pharmacol Biochem Behav 24, 93–98.
Leidenheimer, N. J., & Chapell, R. (1997). Effects of PKC activation and
receptor desensitization on neurosteroid modulation of GABAA recep-
tors. Brain Res Mol Brain Res 52, 173–181.
Leidenheimer, N. J., Browning, M. D., Dunwiddie, T. V., Hahner, L. D., &
Harris, R. A. (1990). Phosphorylation-independent effects of second
messenger system modulators on gamma-aminobutyric acidA receptor
complex function. Mol Pharmacol 38, 823–828.
Leidenheimer, N. J., McQuiklin, S. J., Hahner, L. D., Whiting, P., & Harris,
R. A. (1992). Activation of protein kinase C selectively inhibits the g-
aminobutyric acidA receptor: role of desensitization.Mol Pharmacol 41,
1116–1123.
Lin, Y. F., Angelotti, T. P., Dudek, E. M., Browning, M. D., & MacDon-
ald, R. L. (1996). Enhancement of recombinant a1h1g2L g- amino-
butyric acidA receptor whole-cell currents by protein kinase C is
mediated through phosphorylation of both h1 and g2L subunits.
Mol Pharmacol 50, 184–195.
Lodish, H., Baltimore, D., Berk, A., Zipursky, S. L., Matsuaira, P., &
Darnell, J. (1996). Synthesis and sorting of plasma membrane, se-
cretory, and lysosomal proteins. Molecular Cell Biology (3rd ed.)
(pp. 711–715). New York: Freeman.
Macdonald, R. L. (1995). Ethanol, g-aminobutyrate type A receptors,
and protein kinase C phosphorylation. Proc Natl Acad Sci USA 92,
3633–3635.
MacLennan, A. J., Lee, N., & Walker, D. W. (1995). Chronic ethanol
administration decreases brain-derived neurotrophic factor gene expres-
sion in the rat hippocampus. Neurosci Lett 197, 105–108.
Mahmoudi, M., Kang, M. H., Tillakarartne, N., Tobin, A. J., & Olsen, R.
W. (1997). Chronic intermittent ethanol treatment in rats increases
GABAA receptor a4-subunit expression: possible relevance to alcohol
dependence. J Neurochem 68, 2485–2492.
Majchrowicz, E. (1975). Induction of physical dependence upon ethanol and
the associated behavioral changes. Psychopharmacologia 43, 245–254.
Marszalec, W., Aistrup, G. L., & Narahashi, T. (1998). Ethanol modulation
of excitatory and inhibitory synaptic interactions in cultured cortical
neurons. Alcohol Clin Exp Res 22(7), 1516–1524.
Martz, A., Deitrich, R. A., & Harris, R. A. (1983). Behavioral evidence for
the involvement of gamma-aminobutyric acid in the actions of ethanol.
Eur J Pharmacol 89, 53–62.
Matthews, D. B., Simson, P. E., & Best, P. J. (1995). Acute ethanol impairs
spatial memory but not stimulus/response memory in the rat. Alcohol
Clin Exp Res 19, 902–909.
Matthews, D. B., Devaud, L. L., Fritschy, J. -M., Sieghart, W., & Morrow,
A. L. (1998a). Differential regulation of GABAA receptor gene expres-
sion by ethanol in the rat hippocampus vs. cerebral cortex. J Neurochem
70, 1160–1166.
Matthews, D. B., Devaud, L. L., Kralic, J. E., Fritschy, J. -M., Sieghart, W.,
& Morrow, A. L. (1998b). Chronic MK-801 administration alters
GABAA receptor subunit peptide expression and function in the rat.
Soc Neurosci Abstr 24, 1831.
McDonald, B. J., & Moss, S. J. (1997). Conserved phosphorylation of the
intracellular domains of GABAA receptor h2 and h3 subunits by
cAMP-dependent protein kinase, cGMP-dependent protein kinase, pro-
tein kinase C and Ca2 + /calmodulin type II-dependent protein kinase.
Neuropharmacology 36, 1377–1385.
McDonald, B. J., Amato, A., Connolly, C. N., Benke, D., Moss, S. J., &
Smart, T. G. (1998). Adjacent phosphorylation sites on GABAA recep-
tor h subunits determine regulation by cAMP- dependent protein ki-
nase. Nature Neurosci 1, 23–28.
Mehta, A. K., & Ticku, M. K. (1989). Chronic ethanol treatment alters the
behavioral effects of Ro 15-4513, a partially negative ligand for ben-
zodiazepine binding sites. Brain Res 489, 93–100.
Messing, R. O., Peterson, P. J., & Henrich, C. J. (1991). Chronic ethanol
exposure increases levels of protein kinase Cy and q and protein kinase
C-mediated phosphorylation in cultured neural cells. J Biol Chem 266,
23428–23432.
Mhatre, M. C., & Ticku, M. K. (1992). Chronic ethanol administration
alters g-aminobutyric acid A receptor gene expression. Mol Pharmacol
42, 415–422.
Mhatre, M. C., & Ticku, M. K. (1993). Chronic ethanol treatment down-
regulates GABAA receptor a subunit polypeptide expression in rat
cerebral cortex and cerebellum. Alcohol Clin Exp Res 17, 442.
Mihic, S. J., Ye, Q., Wick, M. J., Koltchine, V. V., Krasowski, M. A.,
Finn, S. E., Mascia, M. P., Valenzuela, C. F., Hanson, K. K., Green-
blatt, E. P., Harris, R. A., & Harrison, N. L. (1997). Sites of alcohol
and volatile anaesthetic action on GABAA and glycine receptors.
Nature 389, 385–389.
Mody, I. (2001). Distinguishing between GABA(A) receptors responsible
for tonic and phasic conductances. Neurochem Res 26, 907–913.
Mohler, H., Fritschy, J. -M., Luscher, B., Rudolph, U., Benson, J., &
Benke, D. (1996). The GABAA receptors: from subunits to diverse
S. Kumar et al. / Pharmacology & Therapeutics 101 (2004) 211–226 225
functions. In T. Narahashi (Ed.), Ion Channels, vol. 4 (pp. 89–111).
New York: Plenum.
Moran, M. H., & Smith, S. S. (1998). Progesterone withdrawal I: pro-
convulsant effects. Brain Res 807, 84–90.
Moran, M. H., Goldberg, N., & Smith, S. S. (1998). Progesterone with-
drawal: II. insensitivity to the sedative effects of a benzodiazepine.
Brain Res 807, 91–100.
Morrow, A. L., Suzdak, P. D., Karanian, J. W., & Paul, S. M. (1988).
Chronic ethanol administration alters g-aminobutyric acid, pentobarbi-
tal and ethanol-mediated 36Cl� uptake in cerebral cortical synaptoneur-
osomes. J Pharmacol Exp Ther 246, 158–164.
Morrow, A. L., Herbert, J. S., & Montpied, P. (1992). Differential effects of
chronic ethanol administration on GABAA receptor a1 and a6 subunit
mRNA levels in rat cerebellum. Mol Cell Neurosci 3, 251–258.
Morrow, A. L., VanDoren, M. J., & Devaud, L. L. (1998). Effects of
progesterone or neuroactive steroid? Nature 395, 652–653.
Morrow, A. L., Janis, G. C., VanDoren, M. J., Matthews, D. B., Samson, H.
H., Janak, P. H., & Grant, K. A. (1999). Neurosteroids mediate phar-
macological effects of ethanol: a new mechanism of ethanol action?
Alcohol Clin Exp Res 23, 1933–1940.
Morrow, A. L., Kumar, S., & Wehner, J. M. (2001a). Chronic ethanol
consumption increases endocytosis of a1 subunit containing GABAA
receptors in rat cortex by a PKC-dependent mechanism. ACNP 40th
Annual Meeting (p. 215). Waikoloa, HI: ACNP Secretariat.
Morrow, A. L., VanDoren, M. J., Penland, S. N., & Matthews, D. B.
(2001b). The role of GABAergic neuroactive steroids in ethanol
action, tolerance and dependence. Brain Res Brain Res Rev 37,
98–109.
Morrow, A. L., Khisti, R. T., Tokunaga, S., McDaniel, J. R., & Matthews,
D. B. (2003). GABAergic neuroactive steroids modulate selective eth-
anol actions: mechanisms and significance. In S. H. Smith (Ed.), Neuro-
steroid Effects in the Central Nervous System: The Role of the GABAA
Receptor ( pp. 219–245). Miami, FL: CRC Press.
Moss, S. J., Doherty, C. A., & Huganir, R. L. (1992a). Identification of the
cAMP-dependent protein kinase and protein kinase C phosphorylation
sites within the major intracellular domains of the h1, g2S and g2L
subunits of the g-aminobutyric acid type A receptor. J Biol Chem 267,
14470–14476.
Moss, S. J., Smart, T. G., Blackstone, C. D., & Huganir, R. L. (1992b).
Functional modulation of GABAA receptors by cAMP-dependent pro-
tein phosphorylation. Science 257, 661–665.
Narita, M., Tamaki, H., Kobayashi, M., Soma, M., & Suzuki, T. (2001).
Changes in Ca2+-dependent protein kinase C isoforms induced by
chronic ethanol treatment in mice. Neurosci Lett 307, 85–88.
Nusser, Z., Sieghart, W., & Mody, I. (1999). Differential regulation of
synaptic GABAA receptors by cAMP-dependent protein kinase in
mouse cerebellar and olfactory bulb neurones. J Physiol 521 (Pt 2),
421–435.
Nymann-Andersen, J.,Wang, H., Chen, L., Kittler, J. T.,Moss, S. J., &Olsen,
R. W. (2002). Subunit specificity and interaction domain between
GABA(A) receptor-associated protein (GABARAP) and GABA(A)
receptors. J Neurochem 80, 815–823.
Obrietan, K., Gao, X. B., & Van Den Pol, A. N. (2002). Excitatory actions
of GABA increase BDNF expression via a MAPK-CREB-dependent
mechanism—a positive feedback circuit in developing neurons. J Neu-
rophysiol 88, 1005–1015.
Oh, S., Jang, C. G., Ma, T., & Ho, I. K. (1999). Activation of protein kinase
C by phorbol dibutyrate modulates GABAA receptor binding in rat
brain slices. Brain Res 850, 158–165.
Olive, M. F., & Hodge, C. W. (2000). Co-localization of PKCq with variousGABAA receptor subunits in the mouse limbic system. NeuroReport 11,
683–687.
Papadeas, S., Grobin, A. C., & Morrow, A. L. (2001). Chronic ethanol
consumption differentially alters GABAA receptor a1 and a4 subunit
peptide expressions and GABAA receptor-mediated 36Cl� uptake in
mesocorticolimbic regions of rat brain. Alcohol Clin Exp Res 25,
1270–1275.
Peng, Z., Hauer, B., Mihalek, R. M., Homanics, G. E., Sieghart, W., Olsen,
R. W., & Houser, C. R. (2002). GABA(A) receptor changes in delta
subunit-deficient mice: altered expression of alpha4 and gamma2 sub-
units in the forebrain. J Comp Neurol 446, 179–197.
Pirker, S., Schwarzer, C., Wieselthaler, A., Sieghart, W., & Sperk, G.
(2000). GABAA receptors: immunocytochemical distribution of 13 sub-
units in the adult rat brain. Neuroscience 101, 815–850.
Poisbeau, P., Cheney, M. C., Browning, M. D., & Mody, I. (1999). Mod-
ulation of synaptic GABAA receptor function by PKA and PKC in adult
hippocampal neurons. J Neurosci 19, 674–683.
Porter, N. M., Twyman, R. E., Uhler, M. D., & Macdonald, R. L. (1990).
Cyclic AMP-dependent protein kinase decreases GABAA receptor cur-
rent in mouse spinal neurons. Neuron 5, 789–796.
Proctor, W. R., Soldo, B. L., Allan, A. M., & Dunwiddie, T. V. (1992).
Ethanol enhances synaptically evoked GABAA receptor-mediated
responses in cerebral cortical neurons in rat brain slices. Brain Res
595, 220–227.
Proctor, W. R., Poelchen, W., Bowers, B. J., Wehner, J. M., Messing, R. O.,
& Dunwiddie, T. V. (2003). Ethanol differentially enhances hippocam-
pal GABAA receptor-mediated responses in protein kinase C gamma
(PKC gamma) and PKC epsilon null mice. J Pharmacol Exp Ther 305,
264–270.
Puia, G., Santi, M., Vincini, S., Pritchett, D. B., Purdy, R. H., Paul, S. M.,
Seeburg, P. H., & Costa, E. (1990). Neurosteroids act on recombinant
human GABAA receptors. Neuron 4, 759–765.
Puia, G., Vincini, S., Seeburg, P. H., & Costa, E. (1991). Influence of
recombinant GABA-A receptor subunit composition on the action of
allosteric modulators of GABA-gated Cl � currents. Mol Pharmacol
39, 691–696.
Reynolds, J. N., Prasad, A., & MacDonald, J. F. (1992). Ethanol modula-
tion of GABA receptor-activated Cl� currents in neurons of the chick,
rat and mouse central nervous system. Eur J Pharmacol 224, 173–181.
Robello, M., Amico, C., & Cupello, A. (1993). Regulation of GABAA
receptor in cerebellar granule cells in culture: differential involvement
of kinase activities. Neuroscience 53, 131–138.
Robello, M., Amico, C., & Cupello, A. (1997). A dual mechanism for
impairment of GABAA receptor activity by NMDA receptor activation
in rat cerebellum granule cells. Eur Biophys J 25, 181–187.
Roberto, M., Madamba, S. G., Moore, S. D., Tallent, M. K., & Siggins, G.
R. (2003). Ethanol increases GABAergic transmission at both pre- and
postsynaptic sites in rat central amygdala neurons. Proc Natl Acad Sci
USA 100, 2053–2058.
Romeo, E., Brancati, A., De Lorenzo, A., Fucci, P., Furnari, C., Pompili,
G. F., Sasso, G. F., Spalletta, G., Troisi, A., & Pasini, A. (1996).
Marked decrease of plasma neuroactive steroids during alcohol with-
drawal. J Pharmacol Exp Ther 247, 309–322.
Sapp, D. W., & Yeh, H. H. (1998). Ethanol-GABAA receptor interactions: a
comparison between cell lines and cerebellar Purkinje cells. J Pharma-
col Exp Ther 284, 768–776.
Sassoe-Pognetto, M., Panzanelli, P., Sieghart, W., & Fritschy, J. M. (2000).
Colocalization of multiple GABA(A) receptor subtypes with gephyrin
at postsynaptic sites. J Comp Neurol 420, 481–498.
Seeburg, P. H., Wisden, W., Verdoorn, T. A., Pritchett, D. B., Werner, P.,
Herb, A., Luddens, H., Sprengel, R., & Sakmann, B. (1990). The
GABAA receptor family: molecular and functional diversity. Cold
Spring Harbor Symp Quant Biol 55, 29–38.
Sibille, E., Pavlides, C., Benke, D., & Toth, M. (2000). Genetic inactivation
of the serotonin1A receptor in mice results in downregulation of major
GABAA receptor a subunits, reduction of GABAA receptor binding,
and benzodiazepine-resistant anxiety. J Neurosci 20, 2758–2765.
Sieghart, W. (1989). Multiplicity of GABAA receptors. Trends Pharmacol
Sci 10, 407–409.
Sieghart, W. (2000). Unraveling the function of GABAA receptor subtypes.
Trends Pharmacol Sci 21, 411–413.
Sieghart, W., & Sperk, G. (2002). Subunit composition, distribution and
function of GABA(A) receptor subtypes. Curr Top Med Chem 2,
795–816.
S. Kumar et al. / Pharmacology & Therapeutics 101 (2004) 211–226226
Sieghart, W., Fuchs, K., Tretter, V., Ebert, V., Jechlinger, M., Hoger, H., &
Adamiker, D. (1999). Structure and subunit composition of GABAA
receptors. Neurochem Int 34, 379–385.
Sik, A., Gulacsi, A., Lai, Y., Doyle, W. K., Pacia, S., Mody, I., & Freund, T.
F. (2000). Localization of the A kinase anchoring protein AKAP79 in
the human hippocampus. Eur J Neurosci 12, 1155–1164.
Smith, S. S., Gong, Q. H., Hsu, F. -C., Markowitz, R. S., Ffrench-Mullen, J.
M. H., & Li, X. (1998a). GABAA receptor a4 subunit suppression
prevents withdrawal properties of an endogenous steroid. Nature 392,
926–930.
Smith, S. S., Gong, Q. H., Li, X., Moran, M. H., Bitran, D., Frye, C. A.,
Hsu, F. (1998b). Withdrawal from 3a-OH-5a-pregnan-20-one using a
pseudopregnancy model alters the kinetics of hippocampal GABAA-
gated current and increases the GABAA receptor a4 subunit in associ-
ation with increased anxiety. J Neurosci 18, 5275–5284.
Soldo, B. L., Proctor, W. R., & Dunwiddie, T. V. (1994). Ethanol differ-
entially modulates GABAA receptor-mediated chloride currents in hip-
pocampal, cortical, and septal neurons in rat brain slices. Synapse 18,
94–103.
Sundstrom-Poromaa, I., Smith, D. H., Gong, Q. H., Sabado, T. N., Li, X.,
Light, A., Wiedmann, M., Williams, K., & Smith, S. (2002). Hormon-
ally regulated a4h2y GABAA receptors are a target for alcohol. Nat
Neurosci 5, 721–722.
Takebayashi, M., Kagaya, A., Uchitomi, Y., Yokota, N., Horiguchi, J., &
Yamawaki, S. (1998). Differential regulation by pregnenolone sulfate of
intracellular Ca2 + increase by amino acids in primary cultured rat
cortical neurons. Neurochem Int 32, 205–211.
Tapia-Arancibia, L., Rage, F., Givalois, L., Dingeon, P., Arancibia, S., &
Beauge, F. (2001). Effects of alcohol on brain-derived neurotrophic
factor mRNA expression in discrete regions of the rat hippocampus
and hypothalamus. J Neurosci Res 63, 200–208.
Thiele, T. E., Willis, B., Stadler, J., Reynolds, J. G., Bernstein, I. L., &
McKnight, G. S. (2000). High ethanol consumption and low sensitivity
to ethanol-induced sedation in protein kinase A-mutant mice. J Neuro-
sci 20, RC75.
Ticku, M. K., & Mehta, A. K. (1990). Gamma-aminobutyric acidAreceptor desensitization in mice spinal cord cultured neurons: lack
of involvement of protein kinases A and C. Mol Pharmacol 38,
719–724.
Tretter, V., Ehya, N., Fuchs, K., & Sieghart, W. (1997). Stoichiometry and
assembly of a recombinant GABAA receptor subtype. J Neurosci 17,
2728–2737.
Ulfig, N., & Setzer, M. (1999). Expression of a kinase anchoring protein 79
in the human fetal amygdala. Microsc Res Tech 46, 48–52.
VanDoren, M. J., Matthews, D. B., Janis, G. C., Grobin, A. C., Devaud, L.
L., & Morrow, A. L. (2000). Neuroactive steroid 3a-hydroxy-5a-preg-
nan-20-one modulates electrophysiological and behavioral actions of
ethanol. J Neurosci 20, 1982–1989.
Wafford, K. A., Thompson, S. A., Thomas, D., Sikela, J., Wilcox, A. S., &
Whiting, P. J. (1996). Functional characterization of human gamma-
aminobutyric acidA receptors containing the alpha4 subunit. Mol Phar-
macol 50, 670–678.
Wallner, M., Hanchar, H. J., & Olsen, R. W. (2003). Ethanol enhances
a4h3y and a6h3yg-aminobutyric acid type A receptors at low concen-
trations known to affect humans. Proc Natl Acad Sci USA 100 (25),
15218–15223.
Wan, F. -J., Berton, F., Madamba, S. G., Francesconi, W., & Siggins, G. R.
(1996). Low ethanol concentrations enhance GABAergic inhibitory
postsynaptic potentials in hippocampal pyramidal neurons only after
block of GABAB receptors. Proc Natl Acad Sci USA 93, 5049–5054.
Wang, H. B., & Olsen, R. W. (2000). Binding of the GABAA receptor-
associated protein (GABARAP) to microtubules and microfilaments
suggests involvement of the cytoskeleton in GABARAP-GABAA re-
ceptor interaction. J Neurochem 75, 644–655.
Wang, Y., Freund, R. K., & Palmer, M. R. (1999). Potentiation of ethanol
effects in cerebellum by activation of endogenous noradrenergic inputs.
J Pharmacol Exp Ther 288, 211–220.
Weiner, J. L., Zhang, L., & Carlen, P. L. (1994). Potentiation of GABAA-
mediated synaptic current by ethanol in hippocampal CA1 neurons:
possible role of protein kinase C. J Pharmacol Exp Ther 268,
1388–1395.
Weiner, J. L., Gu, C., & Dunwiddie, T. V. (1997a). Differential ethanol
sensitivity of subpopulations of GABAA synapses onto rat hippocampal
CA1 pyramidal neurons. J Neurophysiol 77, 1306–1312.
Weiner, J. L., Valenzuela, C. F., Watson, P. L., Frazier, C. J., & Dunwiddie,
T. V. (1997b). Elevation of basal protein kinase C activity increases
ethanol sensitivity of GABAA receptors in rat hippocampal CA1 pyra-
midal neurons. J Neurochem 68, 1949–1959.
Wetsel, W. C., Khan, W. A., Merchenthaler, I., Rivera, H., Halpern, A. E.,
Phung, H. M., Negro-Vilar, A., & Hannun, Y. A. (1992). Tissue and
cellular distribution of the extended family of protein kinase C isoen-
zymes. J Cell Biol 117, 121–133.
Whittemore, E. R., Yang, W., Drewe, J. A., & Woodward, R. M. (1996).
Pharmacology of the human gamma-aminobutyric acidA alpha4 subunit
expressed in Xenopus laevis oocytes. Mol Pharmacol 50, 1365–1375.
Wisden, W., Herb, A., Wieland, H., Keinanen, K., Luddens, H., & Seeburg,
P. H. (1991). Cloning, pharmacological characteristics and expression
pattern of the rat GABAA receptor4 subunit. FEBS Lett 289, 227–230.
Yoshida, Y., Huang, F. L., Nakabayashi, H., & Huang, K. P. (1988). Tissue
distribution and developmental expression of protein kinase C iso-
zymes. J Biol Chem 263, 9868–9873.
Zafra, F., Castren, E., Thoenen, H., & Lindholm, D. (1991). Interplay
between glutamate and gamma-aminobutyric acid transmitter systems
in the physiological regulation of brain-derived neurotrophic factor and
nerve growth factor synthesis in hippocampal neurons. Proc Natl Acad
Sci USA 88, 10037–10041.